Veracyte reported $-7474000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acceleron Pharma XLRN:US $ -63.66M 0.06M
Agenus AGEN:US $ -66.4M 25.02M
Agilent A:US $ 336M 48M
Anika Therapeutics ANIK:US $ 9.18M 7.92M
Arrowhead Research ARWR:US $ -31868000 3.64M
Biocept BIOC:US $ -1.75M 4.41M
Bruker BRKR:US $ 85.6M 3.5M
Dicerna Pharmaceuticals DRNA:US $ -40.24M 11.14M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Heron Therapeutics HRTX:US $ -60.47M 8.36M
Illumina ILMN:US $ 187M 6M
Immunogen IMGN:US $ -27.37M 1.55M
Intrexon XON:US $ -15.67M 2.01M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Laboratory Of America LH:US $ 704.1M 353.8M
Ligand Pharmaceuticals LGND:US $ 45.74M 45.82M
Luminex LMNX:US $ 13.46M 2.96M
Myriad Genetics MYGN:US $ -20.8M 25.9M
Rigel Pharmaceuticals RIGL:US $ -13.05M 54.8M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Siemens SIE:GR 1.66B 188M
Sonic Healthcare SHL:AU $ 925.75M 69.61M
Thermo Fisher Scientific TMO:US $ 2163M 886M
Veracyte VCYT:US $ -7.47M 37.94M
Waters WAT:US $ 196.42M 25.15M